Diabetes · Adults with mental disorders in low‐ and middle‐income countries
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drop‐out Objective · Adults with mental disorders in low‐ and middle‐income countries
Melatonin showed no clear difference in drop‐outs (8 weeks) compared with placebo (low certainty).
1 finding from 1 review
Fasting blood glucose (mg/dL) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Fasting blood glucose (8 to 12 weeks) (change from baseline data) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Body‐mass index (BMI) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Total nocturnal sleep time (minutes) · sleep disturbances in dementia
1 finding from 1 review
Consolidated sleep time · sleep disturbances in dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of nocturnal awakenings · sleep disturbances in dementia
1 finding from 1 review
Number of participants reporting an adverse event · sleep disturbances in dementia
Melatonin showed no clear difference in reporting ≥ 1 adverse event compared with placebo (low certainty).
1 finding from 1 review
Cognitive function · sleep disturbances in dementia
1 finding from 1 review
Quality of life · sleep disturbances in dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Carer burden · sleep disturbances in dementia
1 finding from 1 review
Benzodiazepine discontinuation, end of intervention · adults who withdraw from chronic benzodiazepine use
It is very uncertain whether melatonin changes benzodiazepine discontinuation, end of intervention compared with placebo (very low certainty).
1 finding from 1 review
Benzodiazepine discontinuation, longest · adults who withdraw from chronic benzodiazepine use
It is very uncertain whether melatonin changes benzodiazepine discontinuation, longest compared with placebo (very low certainty).
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Total sleep time, next day Diaries and actigraphy. Scale from: 120 to 600. · patients with sleep disturbances caused by shift work
1 finding from 1 review
Total sleep time, next night; · patients with sleep disturbances caused by shift work
1 finding from 1 review
Sleep onset latency ‐ not reported · patients with sleep disturbances caused by shift work
1 finding from 1 review
Sleepiness during the night shift, postintervention; · patients with sleep disturbances caused by shift work
1 finding from 1 review